: Despite advances in our understanding of the TCR/MHC interaction, the biophysical basis of the increased sensitivity of activated T cells was poorly understood. Our recent studies have started to provide a biophysical basis for this enhanced sensitivity. Using peptide loaded MHC-Ig (pepMHC-Ig) dimers, we found that upon activation, T cells develop increased avidity for antigen. This change depends on increased TCR crosslinking and is sensitive to the cholesterol content of the T cell membrane. Activation-induced membrane changes in TCR avidity represent a previously unrecognized means of increasing the sensitivity of activated T cells to antigen. The current proposal will define, mechanistically, the biophysical changes that result in increased TCR avidity, its control by cholesterol, and the physiological importance of TCR crosslinking. Mechanistically, we will determine if activation induced TCR membrane reorganization leads to preformed TCR dimers/oligomers or results from increased crosslinking potential due to changes in membrane fluidity. Further, we hypothesize that CD8 plays a central role in the enhanced MHC-Ig binding seen with T cell activation due to a change in the relationship of CD8 to the TCR complex. Our preliminary data show that changes in cell membrane cholesterol alter both MHC-Ig binding as well as TCR-mediated calcium signaling. To further analyze the effect of cholesterol we will determine the mechanism of action of cholesterol, the link between cholesterol addition and cytoskeleton, and the effects of cholesterol on other aspects of activation, such as changes in cell surface markers, raft formation, and cytokine expression. The physiologic significance of activation induced TCR membrane reorganization will be further defined by analyzing enhanced TCR avidity in in vivo stimulated acutely activated T cells, memory T cells, and """"""""dysfunctional"""""""" T cells. We hypothesize that only when stimulation leads to development of effective immune responses will T cells show enhanced TCR avidity. These studies will further our understanding of increased TCR avidity as a general mechanism for facilitating immune recognition of antigen. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029575-14
Application #
6879043
Study Section
Immunobiology Study Section (IMB)
Program Officer
Kirkham, Perry M
Project Start
1991-01-01
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
14
Fiscal Year
2005
Total Cost
$327,000
Indirect Cost
Name
Johns Hopkins University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Perica, Karlo; Bieler, Joan Glick; Schütz, Christian et al. (2015) Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy. ACS Nano 9:6861-71
Boyle, Sarah; Kolin, David L; Bieler, Joan Glick et al. (2011) Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen. Biophys J 101:L57-9
Chiu, Yen-Ling; Schneck, Jonathan P; Oelke, Mathias (2011) HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTL. J Vis Exp :
Schütz, Christian; Oelke, Mathias; Schneck, Jonathan P et al. (2010) Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'. Immunotherapy 2:539-50
Oelke, Mathias; Schneck, Jonathan P (2010) Overview of a HLA-Ig based ""Lego-like system"" for T cell monitoring, modulation and expansion. Immunol Res 47:248-56
Durai, Malarvizhi; Krueger, Christine; Ye, Zhaohui et al. (2009) In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC). Cancer Immunol Immunother 58:209-20
Webb, Tonya J; Bieler, Joan G; Schneck, Jonathan P et al. (2009) Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. J Immunol Methods 346:38-44
Webb, Tonya J; Giuntoli 2nd, Robert L; Rogers, Ophelia et al. (2008) Ascites specific inhibition of CD1d-mediated activation of natural killer T cells. Clin Cancer Res 14:7652-8
Tao, Sheng-Ce; Li, Yu; Zhou, Jiangbing et al. (2008) Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology 18:761-9
Shaikh, S R; Mitchell, D; Carroll, E et al. (2008) Differential effects of a saturated and a monounsaturated fatty acid on MHC class I antigen presentation. Scand J Immunol 68:30-42

Showing the most recent 10 out of 24 publications